ArticleProceedings (Baylor University. Medical Center)2014
Multiorgan dysfunction related to chronic ketamine abuse.
Article in Proceedings (Baylor University. Medical Center), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 27 citations in OpenAlex.
- Drug-laced vaping-implications and emerging perioperative challenges for the anesthesiologist: a narrative review.Canadian journal of anaesthesia = Journal canadien d'anesthesie · 2026Review
- Hepatic Safety of Ketamine and Esketamine for Treatment-Resistant Depression: A Real-World Cohort Study.Journal of clinical psychopharmacology · 2026Article
- The Role of Psychedelics in the Treatment of Substance Use Disorders: An Overview of Systematic Reviews.Brain sciences · 2025Review
- Ketamine Hepatotoxicity: An Underappreciated Cause of Liver Damage - Analysis by RUCAM.Journal of clinical and translational hepatology · 2025Article
- Hepatobiliary Complications Associated With Ketamine Use: Clinical Insights and Future Directions.Cureus · 2025Review
- Ketamine-induced urological toxicity: potential mechanisms and translation for adults with mood disorders receiving ketamine treatment.Psychopharmacology · 2021Review
- Disruption of Cav1.2-mediated signaling is a pathway for ketamine-induced pathology.Nature communications · 2020Article
- Suppression of mIFrontiers in pharmacology · 2020Article
- Intact urothelial barrier function in a mouse model of ketamine-induced voiding dysfunction.American journal of physiology. Renal physiology · 2016Article
- Environmental enrichment and abstinence attenuate ketamine-induced cardiac and renal toxicity.Scientific reports · 2015Article
- Ketamine-an update on its clinical uses and abuses.CNS neuroscience & therapeutics · 2014Review
- Evaluating oral ketamine's adverse side effects in chronic pain patients.Saudi journal of anaesthesiaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ketamine abuse is being increasingly reported worldwide. The drug can produce a dissociative state and hallucinations, making ketamine a favorite recreational agent among drug addicts. Chronic ketamine abuse can damage many organs, including the brain, heart, liver, gastrointestinal tract, and genitourinary system. We report a patient with chronic ketamine abuse who presented with severe cachexia, upper gastrointestinal involvement, hepatobiliary dysfunction, and acute kidney injury.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.